Feasibility and outcome of mitral valve repair in patients with infective endocarditis

Autor: Nicola Zoppetti, Valentina Scheggi, Niccolò Marchionni, Alterini Brunetto, Alfredo Cerillo, Iacopo Olivotto, Stefano Del Pace, Pierluigi Stefàno
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: The Cardiothoracic Surgeon, Vol 28, Iss 1, Pp 1-10 (2020)
Journal of the Egyptian Society of Cardio-Thoracic Surgery 28 (2020). doi:10.1186/s43057-020-00037-w
info:cnr-pdr/source/autori:Valentina Scheggi, Iacopo Olivotto, Stefano Del Pace, Nicola Zoppetti, Alterini Brunetto, Niccolò Marchionni, Alfredo Cerillo & Pier Luigi Stefàno/titolo:Feasibility and outcome of mitral valve repair in patients with infective endocarditis/doi:10.1186%2Fs43057-020-00037-w/rivista:Journal of the Egyptian Society of Cardio-Thoracic Surgery/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:28
ISSN: 2662-2203
Popis: Background Valve repair is the treatment of choice for native mitral valve regurgitation. The feasibility of repair when the defect is caused by acute infective endocarditis (IE) is debated. This study aims to compare the outcome of repair and replacement procedures, to report the rate of repair in a single surgical center, and to review the literature on this topic. Results We retrospectively analyzed 108 patients with native mitral IE, potentially eligible for surgical repair. Of these 108, 90 (83%) underwent surgery, and 18 were treated conservatively. Among the 90 surgical patients, 57 (63%) underwent valve replacement and 33 valve repair (37%). The mean follow-up duration was 3 years. The two primary endpoints were mortality and freedom from recurrent endocarditis. Secondary endpoints were the post-operative incidence of major adverse events (hospitalization for any cause, pacemaker implantation, new onset of atrial fibrillation, sternal dehiscence), left ventricular systolic function (LVSF), and valvular function at 1-year echocardiographic follow-up. All-cause mortality was lower for valve repair, although not significantly (p = 0.86), as well as nonfatal adverse events (p = 0.92) and relapse rate (p = 0.20) at 3 years. We did not find differences between the two groups at echocardiographic follow-up, neither for left ventricular systolic function (p = 0.22), nor for valvular continence (p = 0.28). Conclusions In our experience, the mid-term outcome of repair in IE is comparable to valve replacement and should be considered whenever possible, as in degenerative valve disease. The review of the literature supports this strategy.
Databáze: OpenAIRE
Externí odkaz: